Does Health In Tech report any disagreement with Dustin Plantholt related to his departure?

The company explicitly states that Mr. Plantholt’s departure as Chief AI & Marketing Officer is part of a business transition. It clarifies that it did not result from any disagreement about Health In Tech’s operations, policies, or business practices.

Health In Tech executive departs, signs consulting deal

Health In Tech, Inc. reported that Dustin Plantholt will depart from his role as Chief AI & Marketing Officer, effective April 30, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Health In Tech, Inc. reported that Dustin Plantholt will depart from his role as Chief AI & Marketing Officer, effective April 30, 2026. The company states this change is part of a business transition and not due to any disagreement over operations, policies, or practices.

HITChain Inc., a subsidiary, entered into a Consulting Agreement dated May 1, 2026 with Plantholt Advisory Group LLC, owned and controlled by Mr. Plantholt. Under this arrangement, the consultant will receive monthly compensation and Mr. Plantholt will be granted 500,000 restricted shares of HITChain common stock, vesting in equal monthly installments over 12 months, subject to continued service. Either party may terminate the agreement with ten days’ prior written notice.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Departure effective date: April 30, 2026 Notice date: April 27, 2026 Consulting start date: May 1, 2026 +3 more

6 metrics

Departure effective date April 30, 2026 Effective date of Dustin Plantholt’s departure as Chief AI & Marketing Officer

Notice date April 27, 2026 Date formal notice of Mr. Plantholt’s departure was received

Consulting start date May 1, 2026 Date of Consulting Agreement between HITChain and Plantholt Advisory Group LLC

Restricted Stock Award 500,000 shares HITChain common stock granted to Mr. Plantholt under the Equity Incentive Plan

Vesting schedule 12 months Restricted Stock Award vests in equal monthly installments over twelve months

Termination notice period 10 days Either party may terminate the Consulting Agreement with ten days’ prior written notice

Key Terms

emerging growth company, independent contractor agreement, Restricted Stock Award, Equity Incentive Plan, +1 more

5 terms

emerging growth company regulatory

"Emerging growth company Item 5.02."

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

independent contractor agreement financial

"entered into an independent contractor agreement, dated May 1, 2026"

Restricted Stock Award financial

"Mr. Plantholt will receive 500,000 restricted shares of HITChain’s common stock (the “Restricted Stock Award”)"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Equity Incentive Plan financial

"under the HITChain Equity Incentive Plan, which Restricted Stock Award vests"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

emerging growth company regulatory

"Emerging growth company Item 5.02."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did Health In Tech (HIT) disclose in this 8-K filing?

Health In Tech disclosed that Dustin Plantholt will depart as Chief AI & Marketing Officer effective April 30, 2026. The company notes this change is part of a business transition and not due to any disagreement over its operations, policies, or practices.

How will Health In Tech (HIT) continue working with former executive Dustin Plantholt?

After his departure, HIT’s subsidiary HITChain Inc. will retain Plantholt through a Consulting Agreement with Plantholt Advisory Group LLC. He will provide services as an independent contractor in exchange for monthly compensation and an equity-based Restricted Stock Award in HITChain.

What equity compensation is granted under the HITChain Consulting Agreement?

Mr. Plantholt will receive 500,000 restricted shares of HITChain’s common stock as a Restricted Stock Award. These shares vest in equal monthly installments over twelve months, and vesting is conditioned on the consultant continuing to provide services through each applicable vesting date.

Can the Consulting Agreement between HITChain and Plantholt Advisory Group LLC be terminated early?

Yes. The Consulting Agreement may be terminated by either HITChain or Plantholt Advisory Group LLC. Termination requires ten days’ prior written notice from the party choosing to end the agreement, giving both sides a short but defined notice period to adjust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/01/2026 - 04:35 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

April 27, 2026

Date of Report (Date of earliest event reported)

Health In Tech, Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-42449		87-3545722
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

701 S. Colorado Ave, Suite 1

Stuart, FL

34994

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (888) 373-0333

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.001 par value per share

HIT

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Following receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. (the “Company”), effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices. In connection with the conclusion of Mr. Plantholt’s employment, HITChain Inc., a subsidiary of the Company (“HITChain”), entered into an independent contractor agreement, dated May 1, 2026 (the “Consulting Agreement”), with Plantholt Advisory Group LLC, a limited liability company owned and controlled by Mr. Plantholt (the “Consultant”), pursuant to which: (i) the Consultant will receive monthly compensation in exchange for performance of the services and deliverables described in the Consulting Agreement, and (ii) Mr. Plantholt will receive 500,000 restricted shares of HITChain’s common stock (the “Restricted Stock Award”) under the HITChain Equity Incentive Plan, which Restricted Stock Award vests in equal monthly installments over twelve (12) months, subject to the Consultant’s continued service with HITChain through the applicable vesting date. The Consulting Agreement can be terminated by either party upon ten (10) days’ prior written notice. The foregoing description of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Consulting Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.		Description
10.1		Consulting Agreement, dated May 1, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 1, 2026

HEALTH IN TECH, INC.

By:	/s/ Tim Johnson
Name:	Tim Johnson
Title:	Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Agreements & Contracts

EX-10.1 CONSULTING AGREEMENT, DATED MAY 1, 2026 53.1 KB